Abstract
The effects of cisplatin (CDDP) and etoposide (ETP) in combination were evaluated in vitro and in vivo using small cell lung cancer cell lines. The combination effects in vitro were investigated using isohologram analysis. Used together, CDDF and ETP showed a synergistic effect against cell growth on only 1 cell line (SBC‐3), additive effects on 6 (SBC‐2, SBC‐5, Lul30, Lul34AH, Lul35T and H69) and an antagonistic effect on 1 (SBC‐1). In the in vivo experiment, nude mice were inoculated with SBC‐1, SBC‐3 and SBC‐5 cells. Two or 5 mgAg CDDP and 10 or 30 mgAg ETP were administered intraperitoneally alone and simultaneously in combination to nude mice. The in vivo effects of the combination were determined by comparing the observed growth ratio in mice treated with the combination with the expected value of this ratio calculated based on the assumption that the effects of the drugs were simply additive. According to this definition, synergistic effects were observed against all 3 tumors. Thus, the in vivo and in vitro effects differed. The toxicity of the combination therapy, which was analyzed by estimating the body weight change of mice, was no higher than that of CDDP or ETP alone. These results suggest that the excellent clinical effects of CDDP and ETP combination therapy may he attributable not to drug interaction at the cellular level hut to the feasibility of combined use of them at full doses without overlapping side effects.
Keywords: Cisplatin, Etoposide, Combination chemotherapy, Nude mouse, Lung cancer
Full Text
The Full Text of this article is available as a PDF (399.5 KB).
REFERENCES
- 1. ) Einhorn , L. H.Initial therapy with cisplatin plus VP‐16 in small‐cell lung cancer . Semin. Oncol , 13 ( Suppl. 3 ), 5 – 9 ( 1986. ). [PubMed] [Google Scholar]
- 2. ) Loehrer , P. J. , Einhorn , L. H. and Greco , F. A.Cisplatin plus etoposide in small cell lung cancer . Semin. Oncol. , 15 ( Suppl. 3 ), 2 – 8 ( 1988. ). [PubMed] [Google Scholar]
- 3. ) Von Heyden , H. W. , Scherpe , A. and Nagel , G A.cis‐Dichlorodiammineplatinum (II) (cis‐platinum) and etoposide for patients with refractory lymphomas . Cancer Treat Rev. , 9 ( Suppl. A ), 45 – 52 ( 1987. ). [DOI] [PubMed] [Google Scholar]
- 4. ) Hainsworth , J. D. , Williams , S. D. , Einhorn , L. H. , Birch , R. and Greco , F.Successful treatment of resistant germinal neoplasms with VP‐16 and cisplatin , J. Clin. Oncol. , 3 , 666 – 671 ( 1985. ). [DOI] [PubMed] [Google Scholar]
- 5. ) Mosmann , T.Rapid colorimetric assay for cellular growth and survival: application of proliferation and cytotoxicity assays . J. Immunol. Methods , 65 , 55 – 63 ( 1983. ). [DOI] [PubMed] [Google Scholar]
- 6. ) Church , M. W. , Dintcheff , B. A. and Gessner , P. K.The interactive effects of alcohol and cocaine on maternal and fetal toxicity in the Long‐Evans rat . Neurotoxicol Teratol. , 10 , 355 – 361 ( 1988. ). [DOI] [PubMed] [Google Scholar]
- 7. ) Cho , Y. L. , Christensen , C. , Saunders , D. E. , Lawrence , W. D. , Deppe , G. , Malviya , V. K. and Malone , J. M.Combined effects of 1,25‐dihydroxyvitamin D3 and platinum drugs on the growth of MCF‐7 cells . Cancer Res. , 51 , 2848 – 2853 ( 1991. ). [PubMed] [Google Scholar]
- 8. ) Kondo , H. , Kanzawa , F. and Saijo , N.Analysis of in vitro combined effects of cisplatin and etoposide against small cell lung cancer cell lines . J. Jpn. Soc. Cancer Ther. , 28 , 592 – 601 ( 1993. ) ( in Japanese ). [Google Scholar]
- 9. ) Tsai , C. M. , Gazdar , A. F. , Venzon , D. J. , Steinberg , S. M. , Dedrick , R. L. , Mulshine , J. L. and Kramer , B. S.Lack of in vitro synergy between etoposide and cis‐diam‐minedichloroplatinum (II) , Cancer Res. , 49 , 2390 – 2397 ( 1989. ). [PubMed] [Google Scholar]
- 10. ) Ishikura , K. , Fujioka , T. , Hasegawa , M. , Nomura , K. , Okamoto , T. , Tanji , S. and Kubo , T.In vivo antitumor effect of combination therapy with α/β‐interferon and 7‐interferon on a murine renal cell carcinoma . J. Jpn. Soc. Cancer Ther. , 27 , 2020 – 2028 ( 1992. ) ( in Japanese ). [Google Scholar]
- 11. ) Newell , D. R. , Eeles , R. A. , Gumbrell , L. A. , Boxall , F. E. , Horwich , A. and Calvert , A. H.Carboplatin and etoposide pharmacokinetics in patients with testicular teratoma . Cancer Chemother. Pharmacol. , 23 , 367 – 372 ( 1989. ). [DOI] [PubMed] [Google Scholar]
- 12. ) D'lncalci , M. , Rossi , C. , Zucchetti , M. , Urso , R. , Cavalli , F. , Mangioni , C. , Willems , Y. and Sessa , C.Pharmacokinetics of etoposide in patients with abnormal renal and hepatic function . Cancer Res. , 46 , 2566 – 2571 ( 1986. ). [PubMed] [Google Scholar]
- 13. ) Pflüger , K. H. , Hahn , M. , Holz , J. B. , Schmidt , L. , Köhl , P. , Fritsch , H. W. , Jungclas , H. and Havemann , K.Pharmacokinetics of etoposide: correlation of pharmacokinetic parameters with clinical conditions . Cancer Chemother. Pharmacol. , 31 , 350 – 356 ( 1993. ). [DOI] [PubMed] [Google Scholar]